biostrategix Peptides: A Company-Profile Due-Diligence Checklist

By What Peptides Editorial Team · Updated 2026-09-14 · Part of Peptide Vendor Reviews: How to Judge a Supplier From Public Evidence

An overview query is usually a request for orientation rather than a verdict: who is this, what do they sell, and is there anything checkable behind the storefront. We have not purchased from biostrategix, we have not tested material, and we have no relationship with the company. What follows is a company-profile checklist, the same one that sits behind every entry in the peptide vendor evaluation index, applied to the questions a reader can answer from public records alone.

Company-profile diligence is a different exercise from product diligence, and it is worth doing first. Product documents can be requested by anyone, but a profile establishes whether there is a legal person who can be held to them. If no legal entity is identifiable, a certificate is unenforceable in practice no matter what it says, because there is nobody on the other side of it. That is why the register search comes before the certificate request, not after.

The checks below are deliberately unglamorous. They are also the ones that survive contact with time, because a filing history and a registered office are far harder to manufacture quickly than a polished storefront or a confident tone.

Business Identity, Address and Named People

The registered entity is the anchor. Take the company name, registration number and jurisdiction from the footer, terms or legal notice, then search the number in the register for that jurisdiction rather than searching the trading name. Match the registered name against the name on the site, note the entity status, and read the incorporation date together with the date of the most recent filing. A young company that files on schedule is a different proposition from an old one that has stopped filing.

Addresses deserve their own pass. A registered office, a trading address, a fulfilment centre and a returns address can legitimately differ, but each difference should be explicable. Check the address on a map and see what is actually there: a unit in an industrial park, a residential address, a mailbox service, or a virtual office shared with dozens of unrelated storefronts. That last pattern is common enough to be worth checking rather than assuming.

Named staff are the weakest signal and should be treated as such. Many perfectly legitimate small companies publish no names at all, so absence proves little. Where names are given, cross-check them against the register's officer list rather than against the company's own team page, and be sceptical of biographies attached to stock photography. Also note whether the site states whether it is a manufacturer, a distributor or a reseller, since the three carry very different documentation obligations, a distinction also drawn in our profile checklist for another vendor in this cluster.

• Search the registration number, not the trading name, in the register.
• Match registered name, entity status and the most recent filing date.
• Check each published address on a map and note what is actually there.
• Cross-check named officers against the register rather than the team page.
• Establish whether the site claims to manufacture, distribute or resell.

Policies and Documents Worth Locating

Published policies are the second profile layer, and the test is accessibility rather than length. A legal or imprint notice should state the registered name, number, jurisdiction and address. Terms of sale should name the governing law and the seller's legal identity, and should be reachable before any account is created. A privacy notice should identify the data controller. A complaint or recall procedure is the one most often missing, and it is the one that matters if a batch-specific problem ever arises.

Product documentation is the third layer. A certificate of analysis should be obtainable per lot rather than as one file shared across the catalogue, and should carry a laboratory name, a method, dates and a signatory. A storage statement should give a temperature range for the lyophilised powder and for any solution, and should acknowledge that repeated freeze-thaw cycling is the usual handling risk. General guidance on those conventions sits in peptide storage best practice.

Where the profile passes but the documentation does not, the gap is informative rather than neutral. It usually means a real entity is trading without a traceable analytical chain, which is a documentation problem rather than a finding about conduct, and should be recorded as such rather than dramatised.

Risk Signals in a Thin Company Profile

The first group of signals concerns identity. No legal entity named anywhere on the site, a registration number that does not resolve, an address that is a mailbox or is shared with dozens of unrelated shops, and a contact route that is a web form plus a free-mail address all point the same way: there is no identifiable counterparty. Each of these can have an innocent explanation, and the point of the check is to notice them, not to convict anyone.

The second group concerns documentation and commercial terms. Missing batch numbers remove traceability entirely. A certificate with no laboratory, date or method cannot be checked. Figures quoted far below the range other sellers publish for the same peptide and quantity need explaining, because synthesis, purification and analysis all consume real resources. Inconsistent naming across one catalogue, policy pages visible only after registration, and settlement methods with no dispute or reversal route belong on the same list.

We have not tested any biostrategix material, we have not contacted the company for this page, and we make no claim about legality or quality. Research peptides carry legal and quality risk that varies by jurisdiction and by intended use, and that risk falls on the buyer. Where a reader wants evidence rather than paperwork, independent analysis of the sample in hand is the only route; third-party peptide testing programmes describes how those work, and the practical guides hub collects the related method and handling material. Consult a licensed clinician and your national regulator before acting.

This page is part of the Peptide Vendor Reviews: How to Judge a Supplier From Public Evidence guide.